HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cholelithiasis associated with medroxyprogesterone acetate therapy in men.

Abstract
Five out of forty-five adult men, 50 years of age or less, who had received, for at least six months, medroxyprogesterone acetate (MPA, Depo Provera) IM, 200-400 mg/week, for prevention of sex-offending or genital-mutilating behavior developed symptomatic cholelithiasis. Thirty of these men were studied with gallbladder ultrasound prospectively off MPA and at six-month intervals while taking the medication and then six months off MPA. Gallstones recovered from two patients were found to have very high cholesterol content, suggesting they were formed in cholesterol supersaturated bile. These findings are consistent with the increased incidence of gallbladder disease related to high-progesterone states and suggest that MPA may be a causative agent in cholelithiasis. The physiologic studies on gallbladder contraction and cholecystokinin release in a subset of the patients failed to provide information on a mechanism for the possible increased incidence of gallbladder disease.
AuthorsW J Meyer 3rd, I Wiener, L E Emory, C M Cole, N Isenberg, C J Fagan, J C Thompson
JournalResearch communications in chemical pathology and pharmacology (Res Commun Chem Pathol Pharmacol) Vol. 75 Issue 1 Pg. 69-84 (Jan 1992) ISSN: 0034-5164 [Print] United States
PMID1385654 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Testosterone
  • Corn Oil
  • Cholecystokinin
  • Medroxyprogesterone Acetate
  • Medroxyprogesterone
Topics
  • Adult
  • Cholecystokinin (metabolism)
  • Cholelithiasis (chemically induced)
  • Corn Oil
  • Gallbladder (drug effects, metabolism)
  • Humans
  • Male
  • Medroxyprogesterone (adverse effects, analogs & derivatives, therapeutic use)
  • Medroxyprogesterone Acetate
  • Middle Aged
  • Prospective Studies
  • Sex Offenses (prevention & control)
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: